Literature DB >> 11432872

JAK/STAT3-dependent activation of the RalGDS/Ral pathway in M1 mouse myeloid leukemia cells.

T Senga1, T Iwamoto, T Kitamura, Y Miyake, M Hamaguchi.   

Abstract

The Ras-related GTPase (Ral) is converted to the GTP-bound form by Ral guanine nucleotide dissociation stimulator (RalGDS), a putative effector protein of Ras. Recently, it was proven that Ral regulates c-Src activity and subsequent phosphorylation of its substrate, STAT3. Here, we show that STAT3 inversely regulates activation of Ral through induction of expression of RalGDS. To identify new leukemia inhibitory factor-induced genes, we have performed representational difference analysis using M1 mouse myeloid leukemia cells and cloned RalGDS. The expression of RalGDS and subsequent activation of RalA were clearly suppressed by a dominant negative form of STAT3 and a JAK inhibitor, JAB/SOCS1/SSI-1, indicating that RalGDS/RalA signaling requires the activation of the JAK/STAT3 pathway. An experiment using a Ras inhibitor demonstrated that full activation of RalA also requires activation of Ras. These results suggest a novel cross-talk between JAK/STAT3 and the Ras/RalGDS/Ral signaling pathways through gp130.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432872     DOI: 10.1074/jbc.M105749200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  Drosophila RalA is essential for the maintenance of Jak/Stat signalling in ovarian follicles.

Authors:  Christian Ghiglione; Olivier Devergne; Delphine Cerezo; Stéphane Noselli
Journal:  EMBO Rep       Date:  2008-06-13       Impact factor: 8.807

2.  Molecular analysis of signaling events mediated by the cytoplasmic domain of leukemia inhibitory factor receptor alpha subunit.

Authors:  Houqi Liu; Shanrong Liu; Shuping Tang; Kaihong Ji; Fengmei Wang; Shijie Hu
Journal:  Mol Cell Biochem       Date:  2004-03       Impact factor: 3.396

3.  The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral.

Authors:  K Osei-Sarfo; L Martello; S Ibrahim; A Pellicer
Journal:  Oncogene       Date:  2011-03-28       Impact factor: 9.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.